BBC 5 live ran a recent piece that aimed to explore why antidepressant prescriptions have doubled in the last ten years. Unfortunately, it failed to address the drivers of this epidemic – industry-backed diagnostic inflation and the lax regulation of medicines.
Interpersonal therapy reduces the risk of postpartum depression in mothers on public assistance during first 6 months after giving birth.
A meta-analysis looks at the effects of researcher background on study findings for trials comparing pharmacotherapy and psychotherapy for depression.
Brief psychodynamic and psychosocial interventions help maintain reduced depressive symptoms
A new study suggests that smoking cessation is related to depressive symptom improvement, but that depression may also make it harder to quit.
Researchers found acupuncture effective in the treatment of chronic pain and depression
A study published in Frontiers in Human Neuroscience proposes a new model for the treatment of adolescents diagnosed with major depressive disorder (MDD).
Use of antidepressants increased the risk of organ-specific malformations in women with depression
Study finds antidepressant use is linked to increase in hip fractures in community-dwelling older adults with and without Alzheimer’s disease.
New research suggests that treatable metabolic abnormalities underlie some treatment-resistant cases of depression—and treating the metabolic condition has the possibility of dramatically reducing depressive symptoms
The researchers conclude that industry funding appears to bias studies towards pharmacotherapy over psychotherapy for the treatment of depression.
A new study shows that airline pilots are at elevated risk for depression, yet encounter barriers to accessing mental health services.
Overall, 16.7% of 242 million US adults reported filling 1 or more prescriptions for psychiatric drugs in 2013.
An investigative report in the Milwaukee-Wisconsin Journal Sentinel explores the pharmaceutical industries involvement in the creation of the ‘mental illness’ known as Premenstrual Dysphoric Disorder...
For MinnPost, Susan Perry discusses that the pharmaceutical industry played in the creation of the ‘mental disorder’ known as premenstrual dysphoric disorder or PMDD....
Instead of reducing risk, the dose reduction recommendation made by the FDA in their safety message was associated with an increase in hospitalizations.
Study reveals data suggesting yogic breathing may be helpful in treating depression for patients who have not respond to antidepressants
The study finds that curcumin may be as efficacious as antidepressant medications, particularly for atypical depression
Children diagnosed with an Autism Spectrum Disorder (ASD) are much more likely to be prescribed a psychotropic medication.
A new study compares exercise, Internet-based cognitive-behavioral therapy (ICBT) and usual care for treating individuals with depression.
The Washington Post investigates the epidemic of suicide and the overuse of psychiatric drugs that is sweeping through towns in Colorado.
When Carina Håkansson sent out an invitation for a symposium on "Pharmaceuticals: Risks and Alternatives," some of the world's top scientists, along with experts-by-experience, came from 13 countries to explore better ways to respond to people in crisis.
A new study finds that individuals being treated with open-label placebos showed significant reductions in pain and disability, even when compared to individuals receiving treatment as usual.
A new study examines the wide range of symptoms that appear on depression rating scales and what the means for the reliability of research.
A group of researchers in Denmark examines what existing animal studies can tell us about the sexual side-effects of SSRI antidepressants.